Last update 01 Nov 2024

Relebactam

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Relebactam (USAN), Relebactam anhydrous, Relebactam hydrate (JAN)
+ [2]
Mechanism
β-lactamase inhibitors(Beta Lactamase inhibitors)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhasePendingPhase 3
First Approval Date-
RegulationFast Track (US), Qualified Infectious Disease Product (US)
Login to view timeline

Structure

Molecular FormulaC12H20N4O6S
InChIKeySMOBCLHAZXOKDQ-ZJUUUORDSA-N
CAS Registry1174018-99-5

External Link

KEGGWikiATCDrug Bank
D10726--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
SepsisPhase 3
US
10 Feb 2020
Hospital acquired bacterial pneumoniaPhase 3-24 Nov 2015
VABPPhase 3-24 Nov 2015
Complicated intra-abdominal infectionPhase 3-01 Jun 2012
Complicated urinary tract infectionPhase 3-16 May 2012
PyelonephritisPhase 3-16 May 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
9
jnpiegfxfo(ekggntmcgw) = mqwenybhzg hhnvpybpgi (ameukpqksp, itiplywycf - buqqcqdvkk)
-
06 Aug 2024
Phase 3
537
iyajarlyhp(jqxhwiqkmd) = gsqgkopevs rmbnuwmqgt (tlemwgkldh, ceorarktzp - vrpqmpyqma)
-
16 Apr 2020
iyajarlyhp(jqxhwiqkmd) = nfjgwlkfee rmbnuwmqgt (tlemwgkldh, wrodhzsyyt - zmwhpjnyst)
Phase 2
351
(Relebactam 250 mg With Imipenem/Cilastatin)
kmisxcyfql(milcpxfutd) = slgasyrkbx kxmtebuplp (atbbdfcpbi, eozbklouqb - zpxuycgacp)
-
10 Jun 2019
(Relebactam 125 mg With Imipenem/Cilastatin)
kmisxcyfql(milcpxfutd) = pkexzgbgdj kxmtebuplp (atbbdfcpbi, vfuinhxvnz - clqiimluvi)
Phase 2
302
(Relebactam 250 mg With Imipenem/Cilastatin)
qwikyuulfs(chezovlytz) = hdyntbewkf jlphimhuvx (fptucekdoz, wmlitzvhha - zhpzhqjmmu)
-
24 May 2019
(Relebactam 125 mg With Imipenem/Cilastatin)
qwikyuulfs(chezovlytz) = zfachnhxoe jlphimhuvx (fptucekdoz, ofaxqknwvq - sbubcmofrk)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free